{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:12:10Z","timestamp":1791227530341,"version":"4.1.0"},"reference-count":161,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,7,2]],"date-time":"2016-07-02T00:00:00Z","timestamp":1467417600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,7,2]],"date-time":"2016-07-02T00:00:00Z","timestamp":1467417600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI078859"],"award-info":[{"award-number":["AI078859"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI074410"],"award-info":[{"award-number":["AI074410"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI043894"],"award-info":[{"award-number":["AI043894"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroimmune Pharmacol"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s11481-016-9692-7","type":"journal-article","created":{"date-parts":[[2016,7,2]],"date-time":"2016-07-02T07:35:00Z","timestamp":1467444900000},"page":"31-50","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Biodegradable Nanoparticles for Delivery of Therapeutics in CNS Infection"],"prefix":"10.1007","volume":"12","author":[{"given":"Catherine","family":"DeMarino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Pleet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Mathiesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazira","family":"El-Hage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatah","family":"Kashanchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,2]]},"reference":[{"issue":"2\u20133","key":"9692_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.addr.2007.03.005","volume":"59","author":"L Aagaard","year":"2007","unstructured":"Aagaard L, Rossi J (2007) RNAi therapeutics: principles, prospects and challenges. Adv Drug Deliv Rev 59(2\u20133):75\u201386","journal-title":"Adv Drug Deliv Rev"},{"key":"9692_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrn1824","volume":"7","author":"N Abbott","year":"2006","unstructured":"Abbott N, R\u00f6nnb\u00e4ck L, Hansson E (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7:41\u201353","journal-title":"Nat Rev Neurosci"},{"issue":"7","key":"9692_CR3","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.1128\/JVI.79.7.4257-4269.2005","volume":"79","author":"E Acheampong","year":"2005","unstructured":"Acheampong E, Parveen Z, Muthoga L, Kalayeh M, Mukhtar M, Pomerants R (2005) Human immunodeficiency virus type 1 nef potently induces apoptosis in primary human brain microvascular endothelial cells via the activation of caspases. J Virol 79(7):4257\u20134269","journal-title":"J Virol"},{"key":"9692_CR4","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nbt.1807","volume":"29","author":"L Alvarez-Erviti","year":"2011","unstructured":"Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood M (2011) Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 29:341\u2013345","journal-title":"Nat Biotechnol"},{"issue":"4","key":"9692_CR5","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.pharma.2013.04.001","volume":"71","author":"K Andrieux","year":"2013","unstructured":"Andrieux K, Couvreur P (2013) Nanomedicine as a promising approach for the treatment and diagnosis of brain diseases: the example of Alzheimer\u2019s disease. Ann Pharm Fr 71(4):225\u2013233","journal-title":"Ann Pharm Fr"},{"key":"9692_CR6","doi-asserted-by":"crossref","unstructured":"Aryani A, Denecke B (2016) Exosomes as a Nanodelivery system: a key to the future of Neuromedicine? Mol Neurobiol 53(2):818\u2013834","DOI":"10.1007\/s12035-014-9054-5"},{"key":"9692_CR7","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jconrel.2015.10.047","volume":"220","author":"A \u00c5slund","year":"2015","unstructured":"\u00c5slund A, Berg S, Hak S, M\u00f8rch \u00dd, Torp S, Sandvig A, Wider\u00f8e M, Hansen R, de Lange DC (2015) Nanoparticle delivery to the brain \u2014 by focused ultrasound and self-assembled nanoparticle-stabilized microbubbles. J Control Release 220:287\u2013294","journal-title":"J Control Release"},{"key":"9692_CR8","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3389\/fncel.2015.00212","volume":"9","author":"V Atluri","year":"2015","unstructured":"Atluri V, Hidalgo M, Samikkannu T, Kurapati KRV, Jayant RD, Sagar V, Nair MPN (2015) Effect of human immunodeficiency virus on blood-brain barrier integrity and function: an update. Front Cell Neurosci 9:212","journal-title":"Front Cell Neurosci"},{"issue":"1\u20133","key":"9692_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0168-3659(01)00530-2","volume":"79","author":"K Avgoustakis","year":"2002","unstructured":"Avgoustakis K, Beletsi A, Panagi Z, Klepetsanis P, Karydas A, Ithakissios D (2002) PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties. J Control Release 79(1\u20133):123\u2013135","journal-title":"J Control Release"},{"issue":"4","key":"9692_CR10","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1111\/j.1471-4159.2004.02373.x","volume":"89","author":"Z Balazs","year":"2004","unstructured":"Balazs Z, Panzenboeck U, Hammer A, Sovic A, Quehenberger O, Malle E, Sattler W (2004) Uptake and transport of high-density lipoprotein (HDL) and HDL-associated \u03b1-tocopherol by an in vitro blood\u2013brain barrier model. J Neurochem 89(4):939\u2013950","journal-title":"J Neurochem"},{"key":"9692_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2003.12.016","volume":"16","author":"P Ballabh","year":"2004","unstructured":"Ballabh P, Braun A, Nedergaard M (2004) The blood\u2013brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis 16:1\u201313","journal-title":"Neurobiol Dis"},{"key":"9692_CR12","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.jconrel.2015.07.030","volume":"219","author":"E Batrakova","year":"2015","unstructured":"Batrakova E, Kim M (2015) Using exosomes, naturally-equipped nanocarriers, for drug delivery. J Control Release 219:396\u2013405","journal-title":"J Control Release"},{"key":"9692_CR13","doi-asserted-by":"crossref","unstructured":"Battaglia L, Gallarate M, Peira E, Chirio D, Muntoni E, Biasibetti E, Capucchio MT, Valazza A, Panciani PP, Lanotte M, Schiffer D, Annovazzi L, Caldera V,Mellai M, Riganti C (2014) Solid lipid nanoparticles for potential doxorubicin delivery in glioblastoma treatment: preliminary in vitro studies. J Pharm Sci.103(7):2157--65","DOI":"10.1002\/jps.24002"},{"key":"9692_CR14","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/B978-0-7020-4088-7.00090-0","volume":"121","author":"M Bilgrami","year":"2014","unstructured":"Bilgrami M, O\u2019Keefe P (2014) Neurologic diseases in HIV-infected patients. Handb Clin Neurol 121:1321\u20131344","journal-title":"Handb Clin Neurol"},{"issue":"8","key":"9692_CR15","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.nano.2012.02.014","volume":"8","author":"K Blecher","year":"2012","unstructured":"Blecher K, Martinez LR, Tuckman-Vernon C, Nacharaju P, Schairer D, Chouake J, Friedman JM, Alfieri A, Guha C, Nosanchuk JD, Friedman AJ (2012) Nitric oxide-releasing nanoparticles accelerate wound healing in NOD-SCID mice. Nanomedicine 8(8):1364\u20131371","journal-title":"Nanomedicine"},{"key":"9692_CR16","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1089\/aid.2010.0295","volume":"27","author":"K Borgmann","year":"2011","unstructured":"Borgmann K, Rao K, Labhasetwar V, Ghorpade A (2011) Efficacy of tat-conjugated ritonavir-loaded nanoparticles in reducing HIV-1 replication in monocyte-derived macrophages and cytocompatibility with macrophages and human neurons. AIDS Res Hum Retrovir 27:853\u2013862","journal-title":"AIDS Res Hum Retrovir"},{"key":"9692_CR17","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.freeradbiomed.2010.04.034","volume":"49","author":"P Cabrales","year":"2010","unstructured":"Cabrales P, Han G, Roche C, Nacharaju P, Friedman AJ, Friedman JM (2010) Sustained release nitric oxide from long-lived circulating nanoparticles. Free Radic Biol Med 49:530\u2013538","journal-title":"Free Radic Biol Med"},{"key":"9692_CR18","doi-asserted-by":"publisher","first-page":"H49","DOI":"10.1152\/ajpheart.00665.2010","volume":"300","author":"P Cabrales","year":"2011","unstructured":"Cabrales P, Han G, Nacharaju P, Friedman AJ, Friedman JM (2011) Reversal of hemoglobin-induced vasoconstriction with sustained release of nitric oxide. Am J Physiol Heart Circ Physiol 300:H49\u2013H56","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"9692_CR19","doi-asserted-by":"crossref","unstructured":"Charafeddine RA, Makdisi J, Schairer D, O\u2019Rourke BP, Diaz-Valencia JD, Chouake J, Kutner A, Krausz A, Adler B, Nacharaju P, Liang H, Mukherjee S, Friedman JM, Friedman A, Nosanchuk JD, Sharp DJ (2015) Fidgetin-like 2: a microtubule-based regulator of wound healing. J Investig Dermatol 135(9):2309\u20132318","DOI":"10.1038\/jid.2015.94"},{"issue":"3","key":"9692_CR20","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/COH.0b013e32835fc601","volume":"8","author":"M Churchill","year":"2013","unstructured":"Churchill M, Nath A (2013) Where does HIV hide? A focus on the central nervous system. Curr Opin HIV AIDS 8(3):165\u2013169","journal-title":"Curr Opin HIV AIDS"},{"key":"9692_CR21","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0304-3940(02)00814-5","volume":"330","author":"C Cioni","year":"2002","unstructured":"Cioni C, Annunziata P (2002) Circulating gp120 alters the blood-brain barrier permeability in HIV-1 gp120 transgenic mice. Neurosci Lett 330:299\u2013301","journal-title":"Neurosci Lett"},{"issue":"11","key":"9692_CR22","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/nrmicro2223","volume":"7","author":"M Coiras","year":"2009","unstructured":"Coiras M, Lopez-Huertas M, Peres-Olmeda M, Alcami J (2009) Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs. Nat Rev Microbiol 7(11):798\u2013812","journal-title":"Nat Rev Microbiol"},{"issue":"7","key":"9692_CR23","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1002\/jps.2600710717","volume":"71","author":"P Couvreur","year":"1982","unstructured":"Couvreur P, Kante B, Grislain L, Roland M, Speiser P (1982) Toxicity of polyalkylcyanoacrylate nanoparticles II: DOXorubicin-loaded nanoparticles. J Pharm Sci 71(7):790\u2013792","journal-title":"J Pharm Sci"},{"key":"9692_CR24","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ejps.2015.07.010","volume":"78","author":"A \u0106uri\u0107","year":"2015","unstructured":"\u0106uri\u0107 A, Keller B, Reul R, M\u00f6schwitzer J, Fricker G (2015) Development and lyophilization of itraconazole loaded poly(butyl cyanoacrylate) nanospheres as a drug delivery system. Eur J Pharm Sci 78:121\u2013131","journal-title":"Eur J Pharm Sci"},{"key":"9692_CR25","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.antiviral.2015.09.013","volume":"123","author":"A Dalpiaz","year":"2015","unstructured":"Dalpiaz A, Fogagnolo M, Ferraro L, Capuzzo A, Pavan B, Rassu G, Salis A, Giunchedi P, Gavini E (2015) Nasal chitosan microparticles target a AIDS prodrug to brain HIV sanctuaries. Antivir Res 123:146\u2013157","journal-title":"Antivir Res"},{"key":"9692_CR26","doi-asserted-by":"publisher","first-page":"7307","DOI":"10.2147\/IJN.S93670","volume":"10","author":"J Da\u0148kov\u00e1","year":"2015","unstructured":"Da\u0148kov\u00e1 J, Buzgo M, Vejpravov\u00e1 J, Kub\u00ed\u010dkov\u00e1 S, Sovkov\u00e1 V, Vyslou\u017eilov\u00e1 L, Mantl\u00edkov\u00e1 A, Ne\u010das A, Amler E (2015) Highly efficient mesenchymal stem cell proliferation on poly-\u03b5-caprolactone nanofibers with embedded magnetic nanoparticles. Int J Nanomedicine 10:7307\u20137317","journal-title":"Int J Nanomedicine"},{"key":"9692_CR27","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1006\/jmbi.2001.5218","volume":"315","author":"D Dantsker","year":"2002","unstructured":"Dantsker D, Samuni U, Friedman AJ, Yang M, Ray A, Friedman JM (2002) Geminate rebinding in trehalose-glass embedded myoglobins reveals residue-specific control of intramolecular trajectories. J Mol Biol 315:239\u2013251","journal-title":"J Mol Biol"},{"issue":"26","key":"9692_CR28","doi-asserted-by":"publisher","first-page":"6202","DOI":"10.1016\/j.biomaterials.2013.05.012","volume":"34","author":"A Date","year":"2014","unstructured":"Date A, Destache C (2014) A review of nanotechnological approaches for the prophylaxis of HIV\/AIDS. Biomaterials 34(26):6202\u20136228","journal-title":"Biomaterials"},{"key":"9692_CR29","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ejpb.2006.09.004","volume":"66","author":"K Derakhshandeh","year":"2007","unstructured":"Derakhshandeh K, Erfan M, Dadashzadeh S (2007) Encapsulation of 9-nitrocamptothecin, a novel anticare drug, in biodegradable nanoparticles: factorial design, characterization, and release kinetics. Eur J Pharm Biopharm 66:34\u201341","journal-title":"Eur J Pharm Biopharm"},{"key":"9692_CR30","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1093\/jac\/dkq318","volume":"65","author":"C Destache","year":"2010","unstructured":"Destache C, Belgum T, Goede M, Shibata A, Belshan M (2010) Antiretroviral release from poly(DL-lactide-co-glycolide) nanoparticles in mice. J Antimicrob Chemother 65:2183\u20132187","journal-title":"J Antimicrob Chemother"},{"key":"9692_CR31","doi-asserted-by":"publisher","first-page":"12844","DOI":"10.1523\/JNEUROSCI.4154-07.2007","volume":"27","author":"E Eugenin","year":"2007","unstructured":"Eugenin E, Berman J (2007) Gap junctions mediate human immunodeficiency virus-bystander killing in astrocytes. J Neurosci 27:12844\u201312850","journal-title":"J Neurosci"},{"key":"9692_CR32","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1523\/JNEUROSCI.3863-05.2006","volume":"26","author":"E Eugenin","year":"2006","unstructured":"Eugenin E, Osiecki K, Lopez L, Goldstein H, Calderon T, Berman J (2006) CCL2\/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS. J Neurosci 26:1098\u20131106","journal-title":"J Neurosci"},{"key":"9692_CR33","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s13365-013-0170-1","volume":"19","author":"A Ferrucci","year":"2013","unstructured":"Ferrucci A, Nonnemacher M, Wigdahl B (2013) Extracellular HIV-1 viral protein R astrocytic glyceraldehyde 3-phosphate dehydrogenase activity and neuronal survival. J Neurovirol 19:239\u2013253","journal-title":"J Neurovirol"},{"issue":"2","key":"9692_CR34","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0168-3659(02)00212-2","volume":"83","author":"C Fonseca","year":"2002","unstructured":"Fonseca C, Simoes S, Gaspar R (2002) Paclitatexel-loaded PLGA nanoparticles:preparation, physiochemical characterization and in vitro anti-tumoral activity. J Control Release 83(2):273\u2013286","journal-title":"J Control Release"},{"key":"9692_CR35","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1517\/17425240903196743","volume":"6","author":"A Friedman","year":"2009","unstructured":"Friedman A, Friedman J (2009) New biomaterials for the sustained release of nitric oxide: past, present and future. Expert Opin Drug Deliv 6:1113\u20131122","journal-title":"Expert Opin Drug Deliv"},{"key":"9692_CR36","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.niox.2008.04.003","volume":"19","author":"AJ Friedman","year":"2008","unstructured":"Friedman AJ, Han G, Navati MS, Chacko M, Gunther L, Alfieri A, Friedman JM (2008) Sustained release nitric oxide releasing nanoparticles: characterization of a novel delivery platform based on nitrite containing hydrogel\/glass composites. Nitric Oxide 19:12\u201320","journal-title":"Nitric Oxide"},{"key":"9692_CR37","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.niox.2011.09.001","volume":"25","author":"AJ Friedman","year":"2011","unstructured":"Friedman AJ, Blecher K, Schairer D, Tuckman-Vernon C, Nacharaju P, Sanchez D, Gialanella P, Martinez LR, Friedman JM, Nosanchuk JD (2011) Improved antimicrobial efficacy with nitric oxide releasing nanoparticle generated S-nitrosoglutathione. Nitric Oxide 25:381\u2013386","journal-title":"Nitric Oxide"},{"key":"9692_CR38","doi-asserted-by":"publisher","first-page":"217","DOI":"10.4161\/viru.2.3.16161","volume":"2","author":"A Friedman","year":"2012","unstructured":"Friedman A, Blecher K, Sanchez D, Tuckman-Vernon C, Gialanella P, Friedman JM, Martinez LR, Nosanchuk JD (2012) Susceptibility of gram-positive and -negative bacteria to novel nitric oxide-releasing nanoparticle technology. Virulence 2:217\u2013221","journal-title":"Virulence"},{"key":"9692_CR39","first-page":"121","volume":"42C","author":"J Friedman","year":"2014","unstructured":"Friedman J, Friedman A, Cabrales P, Navati M, Nachuraju P, Davies K (2014) Harnessing the topical and systemic therapeutic applications of nitric oxide with nitrite based nitric oxide releasing nanoparticles. Nitric Oxide 42C:121\u2013122","journal-title":"Nitric Oxide"},{"key":"9692_CR40","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1211\/jpp.58.5.0005","volume":"58","author":"M Garg","year":"2006","unstructured":"Garg M, Asthana A, Agashe HB, Agrawal GP, Jain NK (2006) Stavudine-loaded mannosylated liposomes: in-vitro anti-HIV-I activity, tissue distribution and pharmacokinetics. J Pharm Pharmacol 58:605\u2013616","journal-title":"J Pharm Pharmacol"},{"key":"9692_CR41","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.ejpb.2014.05.004","volume":"87","author":"L Gastaldi","year":"2014","unstructured":"Gastaldi L, Battaglia L, Peira E, Chirio D, Muntoni E, Solazzi I, Gallarate M, Dosio F (2014) Solid lipid nanoparticles as vehicles of drugs to the brain: current state of the art. Eur J Pharm Biopharm J Arbeitsgemeinschaft F\u00fcr Pharm Verfahrenstechnik EV 87:433\u2013444","journal-title":"Eur J Pharm Biopharm J Arbeitsgemeinschaft F\u00fcr Pharm Verfahrenstechnik EV"},{"issue":"2","key":"9692_CR42","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s11904-015-0266-8","volume":"12","author":"B Gelman","year":"2015","unstructured":"Gelman B (2015) Neupathology of HAND with suppressive antiretroviral therapy: encephalitis and Neurodegenertaion reconsidered. Curr HIV\/AIDS Rep 12(2):272\u2013279","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"2","key":"9692_CR43","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0378-4274(01)00456-8","volume":"126","author":"S Gelperina","year":"2002","unstructured":"Gelperina S, Khalansky A, Skidan I, Smirnova Z, Bobruskin A, Severin S, Turowski B, Zanella F, Kreuter J (2002) Toxicological studies of DOXorubicin bound to polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles in healthy rats and rats with intracranial glioblastoma. Toxicol Lett 126(2):131\u2013141","journal-title":"Toxicol Lett"},{"issue":"2","key":"9692_CR44","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ejpb.2009.09.003","volume":"74","author":"S Gelperina","year":"2010","unstructured":"Gelperina S, Maksimenko O, Khalansky A, Vanchugova L, Shipulo E, Abbasova K, Berdiev R, Wohlfart S (2010) Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: influence of the formulation parameters. Eur J Pharm Biopharm 74(2):157\u2013163","journal-title":"Eur J Pharm Biopharm"},{"key":"9692_CR45","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.nano.2013.06.012","volume":"10","author":"T Gerson","year":"2014","unstructured":"Gerson T, Makarov E, Senanayake T, Gorantla S, Poluektova L, Vinogradov S (2014) Nano-NRTIs demonstrate low neurotoxicity and high antiviral activity against HIV infection in the brain. Nanomedicine 10:177\u2013185","journal-title":"Nanomedicine"},{"key":"9692_CR46","doi-asserted-by":"publisher","first-page":"12034","DOI":"10.1021\/jp9609489","volume":"100","author":"D Gottfried","year":"1996","unstructured":"Gottfried D, Peterson E, Sheikh A, Yang M, Wang J, Friedman J (1996) Evidence for damped hemoglobin dynamics in a room temperature trehalose glass. J Phys Chem 100:12034\u201312042","journal-title":"J Phys Chem"},{"issue":"1\u20132","key":"9692_CR47","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ijpharm.2014.11.042","volume":"482","author":"N Grabowski","year":"2015","unstructured":"Grabowski N, Hillaireau H, Vergnaud J, Tsapis N, Pallardy M, Kerdine-Romer S, Fattal E (2015) Surface coating mediates the toxicity of polymeric nanoparticles towards human-like macrophages. Int J Pharm 482(1\u20132):75\u201382","journal-title":"Int J Pharm"},{"key":"9692_CR48","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1097\/COH.0000000000000108","volume":"9","author":"L Gray","year":"2014","unstructured":"Gray L, Roche M, Flynn J, Wesselingh S, Gorry P, Churchill M (2014) Is the central nervous system a reservoir of HIV-1? Curr Opin HIV AIDS 9:552\u2013558","journal-title":"Curr Opin HIV AIDS"},{"key":"9692_CR49","unstructured":"Guidelines for the Use of Antiretroviral Agents in HIV-1 Infected Adults and Adolescents (2016) https:\/\/aidsinfo.nih.gov\/guidelines\/html\/1\/adult-and-adolescent-treatment-guidelines\/0"},{"issue":"10","key":"9692_CR50","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1023\/A:1018983904537","volume":"16","author":"A Gulyaev","year":"1999","unstructured":"Gulyaev A, Gelperina S, Skidan I, Antropov A, Kivman G, Kreuter J (1999) Significant transport of DOXorubicin into the brain with polysorbate 80-coated nanoparticles. Pharm Res 16(10):1564\u20131569","journal-title":"Pharm Res"},{"key":"9692_CR51","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1007\/s11095-008-9765-2","volume":"26","author":"A Ham","year":"2009","unstructured":"Ham A, Cost M, Sassi A, Dezzutti C, Rohan L (2009) Targeted delivery of PSC-RANTES for HIV-1 prevention using biodegradable nanoparticles. Pharm Res 26:502\u2013511","journal-title":"Pharm Res"},{"key":"9692_CR52","doi-asserted-by":"publisher","first-page":"e7804","DOI":"10.1371\/journal.pone.0007804","volume":"4","author":"G Han","year":"2009","unstructured":"Han G, Martinez LR, Mihu MR, Friedman AJ, Friedman JM, Nosanchuk JD (2009) Nitric oxide releasing nanoparticles are therapeutic for Staphylococcus aureus abscesses in a murine model of infection. PLoS One 4:e7804","journal-title":"PLoS One"},{"key":"9692_CR53","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/j.1743-6109.2009.01507.x","volume":"7","author":"G Han","year":"2010","unstructured":"Han G, Tar M, Kuppam DS, Friedman A, Melman A, Friedman J, Davies KP (2010) Nanoparticles as a novel delivery vehicle for therapeutics targeting erectile dysfunction. J Sex Med 7:224\u2013233","journal-title":"J Sex Med"},{"key":"9692_CR54","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.ajpath.2011.12.013","volume":"180","author":"G Han","year":"2012","unstructured":"Han G, Nguyen LN, Macherla C, Chi Y, Friedman JM, Nosanchuk JD, Martinez LR (2012) Nitric oxide-releasing nanoparticles accelerate wound healing by promoting fibroblast migration and collagen deposition. Am J Pathol 180:1465\u20131473","journal-title":"Am J Pathol"},{"key":"9692_CR55","first-page":"1","volume":"4","author":"A Hanafy","year":"2016","unstructured":"Hanafy A, Farid R, Helmy M, ElGamal E (2016) Pharmacological, toxicological and neuronal localization assessment of galatamine\/chitosan complex nanoparticles in rats: future potential contribution in Alzheimer\u2019s disease management. Drug Deliv 4:1\u201312","journal-title":"Drug Deliv"},{"key":"9692_CR56","first-page":"39","volume":"2","author":"J Hazleton","year":"2010","unstructured":"Hazleton J, Berman J, Eugenin E (2010) Novel mechanisms of central nervous system damage in HIV infection. HIV AIDS (Auckl) 2:39\u201349","journal-title":"HIV AIDS (Auckl)"},{"issue":"3","key":"9692_CR57","doi-asserted-by":"publisher","first-page":"153","DOI":"10.5414\/NPP28153","volume":"28","author":"T Hekmatara","year":"2009","unstructured":"Hekmatara T, Bernreuther C, Khalansky A, Theisen A, Weissenberger J, Matschke J, Gelperina S, Kreuter J, Glatzel M (2009) Efficient systemic therapy of rat glioblastoma by nanoparticle-bound DOXorubicin is due to antiangiogenic effects. Clin Neuropathol 28(3):153\u2013164","journal-title":"Clin Neuropathol"},{"key":"9692_CR58","unstructured":"HIV\/AIDS Fact sheet No.360 (2015) http:\/\/www.who.int\/mediacentre\/factsheets\/fs360\/en"},{"key":"9692_CR59","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1002\/jps.24022","volume":"103","author":"J Hoekman","year":"2014","unstructured":"Hoekman J, Srivastava P, Ho R (2014) Aerosol stable peptide-coated liposome nanoparticles: a proof-of-concept study with opioid fentanyl in enhancing analgesic effects and reducing plasma drug exposure. J Pharm Sci 103:2231\u20132239","journal-title":"J Pharm Sci"},{"issue":"1","key":"9692_CR60","first-page":"16","volume":"1","author":"S Jana","year":"2011","unstructured":"Jana S, Gandhi A, Sen K, Basu S (2011) Natural polymers and their application in drug delivery and biomedical field. J Pharma Sci Tech 1(1):16\u201327","journal-title":"J Pharma Sci Tech"},{"issue":"1","key":"9692_CR61","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.mvr.2006.05.001","volume":"73","author":"J Jeong","year":"2007","unstructured":"Jeong J, Sugii Y, Minamiyama M, Takeuchi H, Okamoto K (2007) Interaction between liposomes and RBC in microvessels in vivo. Microvasc Res 73(1):39\u201347","journal-title":"Microvasc Res"},{"key":"9692_CR62","first-page":"840","volume":"60","author":"S Jin","year":"2005","unstructured":"Jin S, Bi D, Wang J, Wang Y, Hu H, Deng Y (2005) Pharmacokinetics and tissue distribution of zidovudine in rats following intravenous administration of zidovudine myristate loaded liposomes. Pharmazie 60:840\u2013843","journal-title":"Pharmazie"},{"issue":"6","key":"9692_CR63","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1093\/jnen\/64.6.498","volume":"64","author":"G Kanmogne","year":"2005","unstructured":"Kanmogne G, Primeaux C, Grammas P (2005) HIV-1 gp120 proteins alter tight junction protein expression and brain endothelial cell permeability: implication for pathogenesis of HIV-associated dementia. J Neuropathol Exp Neurol 64(6):498\u2013505","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"9692_CR64","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/sj.jcbfm.9600330","volume":"27","author":"G Kanmogne","year":"2007","unstructured":"Kanmogne G, Schall K, Leibhart J, Knipe B, Gendelman H, Persidsky Y (2007) HIV-1 gp120 compromises blood brain barrier integrity and enhances monocyte migration across blood-brain barrier: implication for viral neuropathogensis. J Cereb Blood Flow Metab 27(1):123\u2013134","journal-title":"J Cereb Blood Flow Metab"},{"key":"9692_CR65","first-page":"61","volume":"58","author":"A Kaur","year":"2008","unstructured":"Kaur A, Jain S, Tiwary A (2008) Mannan-coated gelatin nanoparticles for sustained and targeted delivery of didanosine: in vitro and in vivo evaluation. Acta Pharm Zagreb Croat 58:61\u201374","journal-title":"Acta Pharm Zagreb Croat"},{"key":"9692_CR66","doi-asserted-by":"publisher","first-page":"16099","DOI":"10.1021\/bi000536x","volume":"39","author":"I Khan","year":"2000","unstructured":"Khan I, Shannon CF, Dantsker D, Friedman AJ, Perez-Gonzalez-de-Apodaca J, Friedman JM (2000) Sol-gel trapping of functional intermediates of hemoglobin: geminate and bimolecular recombination studies. Biochemistry 39:16099\u201316109","journal-title":"Biochemistry"},{"key":"9692_CR67","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/mt.2009.271","volume":"18","author":"S Kim","year":"2010","unstructured":"Kim S, Peer D, Kumar P, Subramanya S, Wu H, Asthana D, Habiro K, Yang Y, Manjunath N, Shimaoka M, Shankar P (2010) RNAi-mediated CCR5 silencing by LFA-1-targeted nanoparticles prevents HIV infection in BLT mice. Mol Ther 18:370\u2013376","journal-title":"Mol Ther"},{"key":"9692_CR68","first-page":"1525","volume":"7","author":"S Kooijmans","year":"2012","unstructured":"Kooijmans S, Vader P, van Dommelen S, van Solinge W, Schiffelers R (2012) Exosome mimetics: a novel class of drug delivery systems. Int J Nanomedicine 7:1525\u20131541","journal-title":"Int J Nanomedicine"},{"key":"9692_CR69","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.nano.2014.09.004","volume":"11","author":"AE Krausz","year":"2015","unstructured":"Krausz AE, Adler BL, Cabral V, Navati M, Doerner J, Charafeddine RA, Chandra D, Liang H, Gunther L, Clendaniel A, Harper S, Friedman JM, Nosanchuk JD, Friedman AJ (2015) Curcumin-encapsulated nanoparticles as innovative antimicrobial and wound healing agent. Nanomedicine 11:195\u2013206","journal-title":"Nanomedicine"},{"issue":"1","key":"9692_CR70","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0169-409X(00)00122-8","volume":"47","author":"J Kreuter","year":"2001","unstructured":"Kreuter J (2001) Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev 47(1):65\u201381","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"9692_CR71","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3109\/02652048.2012.692491","volume":"30","author":"J Kreuter","year":"2013","unstructured":"Kreuter J (2013) Mechanism of polymeric nanoparticle-based drug transport across the blood-brain barrier (BBB). J Microencapsul 30(1):49\u201354","journal-title":"J Microencapsul"},{"key":"9692_CR72","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.addr.2013.08.008","volume":"71","author":"J Kreuter","year":"2014","unstructured":"Kreuter J (2014) Drug delivery to the central nervous system by polymeric nanoparticles: what do we know? Adv Drug Deliv Rev 71:2\u201314","journal-title":"Adv Drug Deliv Rev"},{"key":"9692_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.colsurfb.2009.09.001","volume":"75","author":"A Kumari","year":"2010","unstructured":"Kumari A, Yadav S, Yadav S (2010) Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B: Biointerfaces 75:1\u201318","journal-title":"Colloids Surf B: Biointerfaces"},{"key":"9692_CR74","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ijpharm.2004.11.025","volume":"290","author":"Y Kuo","year":"2005","unstructured":"Kuo Y (2005) Loading efficiency of stavudine on polybutylcyanoacrylate and methylmethacrylate-sulfopropylmethacrylate copolymer nanoparticles. Int J Pharm 290:161\u2013172","journal-title":"Int J Pharm"},{"key":"9692_CR75","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ijpharm.2006.07.044","volume":"327","author":"Y Kuo","year":"2006","unstructured":"Kuo Y, Chen H (2006) Effect of nanoparticulate polybutylcyanoacrylate and methylmethacrylate\u2013sulfopropylmethacrylate on the permeability of zidovudine and lamivudine across the in vitro blood\u2013brain barrier. Int J Pharm 327:160\u2013169","journal-title":"Int J Pharm"},{"key":"9692_CR76","first-page":"206","volume":"365","author":"Y Kuo","year":"2009","unstructured":"Kuo Y, Chen H (2009) Entrapment and release of saquinavir using novel cationic solid lipid nanoparticles. Int J Pharm 365:206\u2013213","journal-title":"Int J Pharm"},{"key":"9692_CR77","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.colsurfb.2011.09.048","volume":"90","author":"Y Kuo","year":"2012","unstructured":"Kuo Y, Lee C (2012a) Methylmethacrylate-sulfopropylmethacrylate nanoparticles with surface RMP-7 for targeting delivery of antiretroviral drugs across the blood-brain barrier. Colloids Surf B: Biointerfaces 90:75\u201382","journal-title":"Colloids Surf B: Biointerfaces"},{"key":"9692_CR78","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ijpharm.2007.03.012","volume":"340","author":"Y Kuo","year":"2007","unstructured":"Kuo Y, Su F (2007) Transport of stavudine, delavirdine, and saquinavir across the blood-brain barrier by polybutylcyanoacrylate, methylmethacrylate-sulfopropylmethacrylate, and solid lipid nanoparticles. Int J Pharm 340:143\u2013152","journal-title":"Int J Pharm"},{"key":"9692_CR79","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.colsurfb.2014.03.017","volume":"118","author":"P Lai","year":"2014","unstructured":"Lai P, Daear W, L\u00f6benberg R, Prenner E (2014) Overview of the preparation of organic polymeric nanoparticles for drug delivery based on gelatine, chitosan, poly(d,l-lactide-co-glycolic acid) and polyalkylcyanoacrylate. Colloids Surf B: Biointerfaces 118:154\u2013163","journal-title":"Colloids Surf B: Biointerfaces"},{"key":"9692_CR80","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1093\/bjaceaccp\/mkr018","volume":"11","author":"B Lawther","year":"2011","unstructured":"Lawther B, Kumar S, Krovvidi H (2011) Blood\u2013brain barrier. Contin Educ Anaesth Crit Care Pain 11:128\u2013132","journal-title":"Contin Educ Anaesth Crit Care Pain"},{"issue":"2","key":"9692_CR81","first-page":"45","volume":"18","author":"S Letendre","year":"2010","unstructured":"Letendre S, Ellis R, Ances B, McCutchan J (2010) Neurologic complications of HIV disease and their treatment. Top HIV Med 18(2):45\u201355","journal-title":"Top HIV Med"},{"issue":"51","key":"9692_CR82","doi-asserted-by":"publisher","first-page":"28656","DOI":"10.1021\/acsami.5b10534","volume":"7","author":"Q Li","year":"2015","unstructured":"Li Q, Xu S, Zhou H, Wang X, Dong B, Gao H, Tang J, Yang Y (2015) pH and glutathione Dul-responsive dynamic cross-linked Supramolecular network on Mesoporous silica nanoparticles for controlled anticancer drug release. ACS Appl Mater Interfaces 7(51):28656\u201328664","journal-title":"ACS Appl Mater Interfaces"},{"key":"9692_CR83","doi-asserted-by":"publisher","first-page":"6411","DOI":"10.1021\/acsami.6b00959","volume":"8","author":"J Liu","year":"2016","unstructured":"Liu J, Qi C, Tao K, Chang J, Xu L, Giang X, Zhang Y, Huang L, Li Q, Xie H, Gao J, Shuai X, Wang G, Wang Z, Wang L (2016) Sericin\/Dextran Injectable Hydrogel as an Optically Trackable Drug Delivery System for Malignant Melanoma Treatment. ACS Appl Mater Interfaces 8:6411\u20136422","journal-title":"ACS Appl Mater Interfaces"},{"key":"9692_CR84","doi-asserted-by":"publisher","first-page":"719139","DOI":"10.4061\/2011\/719139","volume":"2011","author":"S Mahajan","year":"2011","unstructured":"Mahajan S, Aalinkeel R, Reynolds J, Bindukumar N, Sykes D, Wing-Cheng L, Ding H, Bergey E, Prasad P, Schwartz S (2011) Nanotherapeutics using an HIV-1 poly a and transactivator of HIV-1 LTR-(TAR) specific siRNA. Pathol Res Int 2011:719139","journal-title":"Pathol Res Int"},{"issue":"18","key":"9692_CR85","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1097\/00002030-200212060-00002","volume":"16","author":"M Martinez","year":"2002","unstructured":"Martinez M, Gutierrez A, Armand-Ugon M, Parera M, Gomez J, Clotet B, Este J (2002) Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication. AIDS 16(18):2385\u20132390","journal-title":"AIDS"},{"key":"9692_CR86","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1038\/jid.2009.95","volume":"129","author":"LR Martinez","year":"2009","unstructured":"Martinez LR, Han G, Chacko M, Mihu MR, Jacobson M, Gialanella P, Friedman AJ, Nosanchuk JD, Friedman JM (2009) Antimicrobial and healing efficacy of sustained release nitric oxide nanoparticles against Staphylococcus aureus skin infection. J Investig Dermatol 129:2463\u20132469","journal-title":"J Investig Dermatol"},{"issue":"3","key":"9692_CR87","doi-asserted-by":"publisher","first-page":"e32616","DOI":"10.1371\/journal.pone.0032616","volume":"7","author":"A Mathew","year":"2012","unstructured":"Mathew A, Fukuda T, Nagaoka Y, Hasumura T, Morimoto H, Yoshida Y, Maekawa T, Venugopal K, Kumar D (2012) Curcumin loaded-PLGA nanoparticles conjugated with Tet-1 peptide for potential use in Alzheimer\u2019s disease. PLoS One 7(3):e32616","journal-title":"PLoS One"},{"key":"9692_CR88","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.ultrasmedbio.2007.10.016","volume":"34","author":"N McDannold","year":"2008","unstructured":"McDannold N, Vykhodtseva N, Hynynen K (2008) Blood-brain barrier disruption induced by focused ultrasound and circulating preformed microbubbles appears to be characterized by the mechanical index. Ultrasound Med Biol 34:834\u2013840","journal-title":"Ultrasound Med Biol"},{"key":"9692_CR89","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3390\/pharmaceutics7030275","volume":"7","author":"S Meairs","year":"2015","unstructured":"Meairs S (2015) Facilitation of drug transport across the blood\u2013brain barrier with ultrasound and microbubbles. Pharmaceutics 7:275\u2013293","journal-title":"Pharmaceutics"},{"key":"9692_CR90","first-page":"6433","volume":"9","author":"C Melguizo","year":"2015","unstructured":"Melguizo C, Cabeza L, Prados J, Ortiz R, Caba O, Rama A, Delgado \u00c1, Arias J (2015) Enhanced antitumoral activity of DOXorubicin against lung cancer cells using biodegradable poly(butylcyanoacrylate) nanoparticles. Drug Des Devel Ther 9:6433\u20136444","journal-title":"Drug Des Devel Ther"},{"key":"9692_CR91","doi-asserted-by":"publisher","first-page":"62","DOI":"10.4161\/viru.1.2.10038","volume":"1","author":"MR Mihu","year":"2010","unstructured":"Mihu MR, Sandkovsky U, Han G, Friedman JM, Nosanchuk JD, Martinez LR (2010) The use of nitric oxide releasing nanoparticles as a treatment against Acinetobacter Baumannii in wound infections. Virulence 1:62\u201367","journal-title":"Virulence"},{"key":"9692_CR92","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.nano.2014.09.017","volume":"11","author":"B Mordorski","year":"2015","unstructured":"Mordorski B, Pelgrift R, Adler B, Krausz A, da Costa Neto AB, Liang H, Gunther L, Clendaniel A, Harper S, Friedman JM, Nosanchuk JD, Nacharaju P, Friedman AJ (2015) S-nitrosocaptopril nanoparticles as nitric oxide-liberating and transnitrosylating anti-infective technology. Nanomedicine 11:283\u2013291","journal-title":"Nanomedicine"},{"key":"9692_CR93","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.niox.2012.06.003","volume":"27","author":"P Nacharaju","year":"2012","unstructured":"Nacharaju P, Tuckman-Vernon C, Maier KE, Chouake J, Friedman A, Cabrales P, Friedman JM (2012) A nanoparticle delivery vehicle for S-nitroso-N-acetyl cysteine: sustained vascular response. Nitric Oxide 27:150\u2013160","journal-title":"Nitric Oxide"},{"key":"9692_CR94","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.resuscitation.2010.12.025","volume":"82","author":"P Nachuraju","year":"2011","unstructured":"Nachuraju P, Friedman AJ, Friedman JM, Cabrales P (2011) Exogenous nitric oxide prevents cardiovascular collapse during hemorrhagic shock. Resuscitation 82:607\u2013613","journal-title":"Resuscitation"},{"issue":"11","key":"9692_CR95","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1248\/cpb.58.1423","volume":"58","author":"K Nagpal","year":"2010","unstructured":"Nagpal K, Singh S, Mishra D (2010) Chitosan nanoparticles: a promising system in novel drug delivery. Chem Pharm Bull (Tokyo) 58(11):1423\u20131430","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"9692_CR96","doi-asserted-by":"publisher","first-page":"36021","DOI":"10.1074\/jbc.M606866200","volume":"281","author":"MS Navati","year":"2006","unstructured":"Navati MS, Friedman JM (2006) Sugar-derived glasses support thermal and photo-initiated electron transfer processes over macroscopic distances. J Biol Chem 281:36021\u201336028","journal-title":"J Biol Chem"},{"key":"9692_CR97","doi-asserted-by":"publisher","first-page":"12273","DOI":"10.1021\/ja903364h","volume":"131","author":"MS Navati","year":"2009","unstructured":"Navati MS, Friedman JM (2009) Reactivity of glass-embedded met hemoglobin derivatives toward external NO: implications for nitrite-mediated production of bioactive NO. J Am Chem Soc 131:12273\u201312279","journal-title":"J Am Chem Soc"},{"key":"9692_CR98","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1021\/jp909425z","volume":"114","author":"MS Navati","year":"2010","unstructured":"Navati MS, Friedman JM (2010) Glass matrix-facilitated thermal reduction: a tool for probing reactions of met hemoglobin with nitrite and nitric oxide. J Phys Chem B 114:2938\u20132943","journal-title":"J Phys Chem B"},{"issue":"1\u20132","key":"9692_CR99","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0378-5173(00)00632-3","volume":"214","author":"S Nicoli","year":"2001","unstructured":"Nicoli S, Santi P, Couvreur P, Couarraze G, Colombo P, Fattal E (2001) Design of triptorelin loaded nanosphere for transdermal iontophoretic administration. Int J Pharm 214(1\u20132):31\u201335","journal-title":"Int J Pharm"},{"key":"9692_CR100","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.2217\/nnm.13.108","volume":"8","author":"A Orlando","year":"2013","unstructured":"Orlando A, Re F, Sesana S, Rivolta I, Panariti A, Brambilla D, Nicolas J, Couvreur P, Andrieux K, Masserini M, Cazzaniga E (2013) Effect of nanoparticles binding \u03b2-amyloid peptide on nitric oxide production by cultured endothelial cells and macrophages. Int J Nanomedicine 8:1335\u20131347","journal-title":"Int J Nanomedicine"},{"issue":"45","key":"9692_CR101","doi-asserted-by":"publisher","first-page":"42781","DOI":"10.1074\/jbc.M207601200","volume":"277","author":"U Panzenboeck","year":"2002","unstructured":"Panzenboeck U, Balazs Z, Sovic A, Hrzenjak A, Levak-Frank S, Wintersperger A, Malle E, Satter W (2002) ABCA1 and scavenger receptor class B, type I, are modulators of reverse sterol transport at an in vitro blood-brain barrier constituted of porcine brain capillary endothelial cells. J Biol Chem 277(45):42781\u201342789","journal-title":"J Biol Chem"},{"key":"9692_CR102","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","volume":"2","author":"W Pardridge","year":"2005","unstructured":"Pardridge W (2005) The blood-brain barrier: bottleneck in brain drug development. NeuroRx 2:3\u201314","journal-title":"NeuroRx"},{"issue":"7","key":"9692_CR103","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.addr.2011.12.006","volume":"64","author":"T Patel","year":"2012","unstructured":"Patel T, Zhou J, Piepmeier J, Saltzman W (2012) Polymeric nanoparticles for drug delivery to the central nervous system. Adv Drug Deliv Rev 64(7):701\u2013705","journal-title":"Adv Drug Deliv Rev"},{"key":"9692_CR104","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/0042-6822(85)90246-6","volume":"147","author":"R Peluso","year":"1985","unstructured":"Peluso R, Haase A, Stowring L, Edwards M, Ventura P (1985) A Trojan horse mechanism for the spread of visna virus in monocytes. Virology 147:231\u2013236","journal-title":"Virology"},{"issue":"1\u20132","key":"9692_CR105","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.ijpharm.2007.01.031","volume":"337","author":"E Pereverzeva","year":"2007","unstructured":"Pereverzeva E, Treschalin I, Bodyagin D, Maksimenko O, Langer K, Dreis S, Asmussen B, Kreuter J, Gelperina S (2007) Influence of the formulation on the tolerance profile of nanoparticle-bound DOXorubicin in healthy rats: focus on cardio- and testicular toxicity. Int J Pharm 337(1\u20132):346\u2013356","journal-title":"Int J Pharm"},{"issue":"1","key":"9692_CR106","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.toxlet.2008.01.020","volume":"178","author":"E Pereverzeva","year":"2008","unstructured":"Pereverzeva E, Treschalin I, Bodyagin D, Maksimenko O, Kreuter J, Gelperina S (2008) Intravenous tolerance of a nanoparticle-based formulation of DOXorubicin in healthy rats. Toxicol Lett 178(1):9\u201319","journal-title":"Toxicol Lett"},{"issue":"7","key":"9692_CR107","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.4049\/jimmunol.158.7.3499","volume":"158","author":"Y Persidsky","year":"1997","unstructured":"Persidsky Y, Stins W, Way D, Witte M, Weinand M, Kim K, Bock P, Gendelman H, Fiala M (1997) A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis. J Immunol 158(7):3499\u20133510","journal-title":"J Immunol"},{"issue":"12","key":"9692_CR108","doi-asserted-by":"publisher","first-page":"4770","DOI":"10.1182\/blood-2005-11-4721","volume":"107","author":"Y Persidsky","year":"2006","unstructured":"Persidsky Y, Heilman D, Haorah J, Zelivyanskaya M, Persidsky R, Weber G, Shimokawa H, Kaibuchi K, Ikezu T (2006) Rho-mediated regulation of tight junctions during monocyte migration across the blood-brain barrier in HIV-1 encephalitis (HIVE). Blood 107(12):4770\u20134780","journal-title":"Blood"},{"issue":"1","key":"9692_CR109","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jconrel.2006.10.015","volume":"117","author":"B Petri","year":"2007","unstructured":"Petri B, Bootz A, Khalansky A, Hekmatara T, M\u00fcller R, Uhl R, Kreuter J, Gelperina S (2007) Chemotherapy of brain tumour using DOXorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: revisiting the role of surfactants. J Control Release 117(1):51\u201358","journal-title":"J Control Release"},{"issue":"2","key":"9692_CR110","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s11060-006-9218-x","volume":"81","author":"S Phuphanich","year":"2007","unstructured":"Phuphanich S, Maria B, Braeckman R, Chamberlain M (2007) A pharmacokinetic study of intra-CSF administered encapsulated cytarabine (DepotCyt) for the treatment of neoplastic meningitis in patients with leukemia, lymphoma, or solid tumors as part of a phase III study. J Neuro-Oncol 81(2):201\u2013208","journal-title":"J Neuro-Oncol"},{"key":"9692_CR111","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.colsurfb.2011.04.013","volume":"86","author":"K Prabhakar","year":"2011","unstructured":"Prabhakar K, Afzal SM, Kumar PU, Rajanna A, Kishan V (2011) Brain delivery of transferrin coupled indinavir submicron lipid emulsions--pharmacokinetics and tissue distribution. Colloids Surf B: Biointerfaces 86:305\u2013313","journal-title":"Colloids Surf B: Biointerfaces"},{"issue":"6","key":"9692_CR112","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v26.i6.10","volume":"26","author":"A Puri","year":"2009","unstructured":"Puri A, Loomis K, Smith B, Lee J, Yavlovich A, Heldman E, Blumenthal R (2009) Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic. Crit Rev Ther Drug Carrier Syst 26(6):523\u2013580","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"9692_CR113","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1038\/jid.2015.277","volume":"135","author":"M Qin","year":"2015","unstructured":"Qin M, Landriscina A, Rosen JM, Wei G, Kao S, Olcott W, Agak GW, Paz KB, Bonventre J, Clendaniel A, Harper S, Adler BL, Krausz AE, Friedman JM, Nosanchuk JD, Kim J, Friedman AJ (2015) Nitric oxide-releasing nanoparticles prevent Propionibacterium acnes-induced inflammation by both clearing the organism and inhibiting microbial stimulation of the innate immune response. J Investig Dermatol 135:2723\u20132731","journal-title":"J Investig Dermatol"},{"issue":"6","key":"9692_CR114","doi-asserted-by":"publisher","first-page":"767","DOI":"10.3109\/07420529909016944","volume":"16","author":"P Ramge","year":"1999","unstructured":"Ramge P, Kreuter J, Lemmer B (1999) Circadian phase-dependent Antinociceptive reaction in mice determined by the hot-plate test and the tail-Flick test after intravenous injection of Dalargin-loaded nanoparticles. Chronobiol Int 16(6):767\u2013777","journal-title":"Chronobiol Int"},{"key":"9692_CR115","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1016\/j.biomaterials.2008.08.004","volume":"29","author":"K Rao","year":"2008","unstructured":"Rao K, Reddy M, Horning J, Labhasetwar V (2008) TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs. Biomaterials 29:4429\u20134438","journal-title":"Biomaterials"},{"issue":"8","key":"9692_CR116","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1517\/17425240903081705","volume":"6","author":"K Rao","year":"2009","unstructured":"Rao K, Ghorpade A, Labhasetwar V (2009) Targeting anti-HIV drugs to the CNS. Expert Opin Drug Deliv 6(8):771\u2013784","journal-title":"Expert Opin Drug Deliv"},{"key":"9692_CR117","doi-asserted-by":"publisher","first-page":"7270","DOI":"10.1021\/ja0201348","volume":"124","author":"A Ray","year":"2002","unstructured":"Ray A, Friedman BA, Friedman JM (2002) Trehalose glass-facilitated thermal reduction of metmyoglobin and methemoglobin. J Am Chem Soc 124:7270\u20137271","journal-title":"J Am Chem Soc"},{"issue":"3","key":"9692_CR118","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0168-3659(00)00367-9","volume":"70","author":"H Redhead","year":"2001","unstructured":"Redhead H, Davis S, Illum L (2001) Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterization and in vivo evaluation. J Control Release 70(3):353","journal-title":"J Control Release"},{"issue":"15","key":"9692_CR119","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.1002\/cncr.24359","volume":"115","author":"M Rodriguez","year":"2009","unstructured":"Rodriguez M, Pytlik R, Kozak T, Chhanabhai M, Gascoyne R, Lu B, Deitcher S, Winter J (2009) Vincristine sulfate liposomes injection (Marqibo) in heavily pretreated patients with refractory agggressive non-Hodgkin lymphoma: report of the pivotal phase 2 study. Cancer 115(15):3475\u20133482","journal-title":"Cancer"},{"issue":"2\u20133","key":"9692_CR120","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jconrel.2005.07.024","volume":"108","author":"C Roney","year":"2005","unstructured":"Roney C, Kulkarni P, Arora V, Antich P, Bonte F, Wu A, Mallikarjuana N, Manohar S, Liang H, Kulkarni A, Sung H, Sairam M, Aminabhavi T (2005) Targeted nanoparticles for drug delivery through the blood\u2013brain barrier for Alzheimer\u2019s disease. J Control Release 108(2\u20133):193\u2013214","journal-title":"J Control Release"},{"key":"9692_CR121","doi-asserted-by":"publisher","first-page":"25783","DOI":"10.1074\/jbc.M200301200","volume":"277","author":"U Samuni","year":"2002","unstructured":"Samuni U, Dantsker D, Khan I, Friedman AJ, Peterson E, Friedman JM (2002) Spectroscopically and kinetically distinct conformational populations of sol-gel-encapsulated carbonmonoxy myoglobin. A comparison with hemoglobin. J Biol Chem 277:25783\u201325790","journal-title":"J Biol Chem"},{"key":"9692_CR122","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1021\/bi050010i","volume":"45","author":"U Samuni","year":"2006","unstructured":"Samuni U, Roche CJ, Dantsker D, Juszczak LJ, Friedman JM (2006) Modulation of reactivity and conformation within the T-quaternary state of human hemoglobin: the combined use of mutagenesis and sol-gel encapsulation. Biochemistry 45:2820\u20132835","journal-title":"Biochemistry"},{"key":"9692_CR123","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/978-88-470-0807-6_13","volume-title":"Dioxygen binding and sensing proteins. A tribute to Beatrice and Jonathan Wittenberg","author":"U Samuni","year":"2008","unstructured":"Samuni U, Roche C, Dantsker D, Friedman J (2008) T- and R-state tertiary relaxations in Sol-gel encapsulated Haemoglobin. In: Bolognesi M, Verde C (eds) Dioxygen binding and sensing proteins. A tribute to Beatrice and Jonathan Wittenberg. Springer, Berlin, pp. 133\u2013159"},{"key":"9692_CR124","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.nano.2013.06.002","volume":"10","author":"DA Sanchez","year":"2014","unstructured":"Sanchez DA, Schairer D, Tuckman-Vernon C, Chouake J, Kutner A, Makdisi J, Friedman JM, Nosanchuk JD, Friedman AJ (2014) Amphotericin B releasing nanoparticle topical treatment of Candida spp. in the setting of a burn wound. Nanomedicine 10:269\u2013277","journal-title":"Nanomedicine"},{"key":"9692_CR125","doi-asserted-by":"publisher","first-page":"62","DOI":"10.4161\/viru.3.1.18816","volume":"3","author":"D Schairer","year":"2012","unstructured":"Schairer D, Martinez LR, Blecher K, Chouake J, Nacharaju P, Gialanella P, Friedman JM, Nosanchuk JD, Friedman A (2012) Nitric oxide nanoparticles: pre-clinical utility as a therapeutic for intramuscular abscesses. Virulence 3:62\u201367","journal-title":"Virulence"},{"key":"9692_CR126","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1365-2990.1997.tb01190.x","volume":"23","author":"D Seilhean","year":"1997","unstructured":"Seilhean D, Dzia-Lepfoundzou A, Sazdovitch V, Cannella B, Raine C, Katlama C, Bricaire F, Duyckaerts C, Hauw J (1997) Astrocytic adhesion molecules are increased in HIV-1-associated cognitive\/motor complex. Neuropathol Appl Neurobiol 23:83\u201392","journal-title":"Neuropathol Appl Neurobiol"},{"key":"9692_CR127","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jconrel.2014.12.042","volume":"200","author":"M Serramia","year":"2015","unstructured":"Serramia M, Alvarez S, Fuentes-Paniagua E, Clemente M, Sanchez-Nieves J, Gomez R, de la Mata J, Munoz-Fernandez A (2015) In vivo delivery of siRNA to the brain by carbosilane dendrimer. J Control Release 200:60\u201370","journal-title":"J Control Release"},{"issue":"10","key":"9692_CR128","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1007\/s11095-014-1370-y","volume":"31","author":"L Shah","year":"2014","unstructured":"Shah L, Kulkarni P, Ferris C, Amiji M (2014) Analgesic efficacy and safety of DALDA peptide analog delivery to the brain using oil-in-water nanoemulsion formulation. Pharm Res 31(10):2724\u20132734","journal-title":"Pharm Res"},{"key":"9692_CR129","doi-asserted-by":"crossref","first-page":"250","DOI":"10.31768\/2312-8852.2015.37(4):250-254","volume":"37","author":"I Shton","year":"2015","unstructured":"Shton I, Sarnatskaya V, Prokopenko I, Gamaleia N (2015) Chlorin e6 combined with albumin nanoparticles as a potential composite photosensitizer for photodynamic therapy of tumors. Exp Oncol 37:250\u2013254","journal-title":"Exp Oncol"},{"key":"9692_CR130","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nm880","volume":"9","author":"J Siliciano","year":"2003","unstructured":"Siliciano J, Kajdas J, Finzi D, Quinn T, Chadwick K, Margolick J, Kovacs C, Gange S, Siliciano R (2003) Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nat Med 9:727\u2013728","journal-title":"Nat Med"},{"key":"9692_CR131","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1186\/1471-2202-9-S3-S4","volume":"9","author":"GA Silva","year":"2008","unstructured":"Silva GA (2008) Nanotechnology approaches to crossing the blood-brain barrier and drug delivery to the CNS. BMC Neurosci 9:S4","journal-title":"BMC Neurosci"},{"issue":"2","key":"9692_CR132","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.nano.2015.10.022","volume":"12","author":"W Song","year":"2016","unstructured":"Song W, Tang Z, Lei T, Wen X, Wang G, Zhang D, Deng M, Tang X, Chen X (2016) Stable loading and delivery of disulfiram with mPEG-PLGA\/PCL mixed nanoparticles for tumor therapy. Nanomedicine 12(2):377\u2013386","journal-title":"Nanomedicine"},{"issue":"1\u20132","key":"9692_CR133","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0168-3659(00)00339-4","volume":"70","author":"K Soppimath","year":"2001","unstructured":"Soppimath K, Aminabhavi T, Kulkarni A, Rudzinski W (2001) Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release 70(1\u20132):1\u201320","journal-title":"J Control Release"},{"issue":"2","key":"9692_CR134","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0165-5728(99)00170-8","volume":"102","author":"B Sporer","year":"2000","unstructured":"Sporer B, Koedel U, Paul R, Kohleisen B, Erfle V, Fontana A, Pfister H (2000) Human immunodeficiency virus type-1 nef protein induces blood-brain barrier disruption in the rat: role of matrix metalloproteinase-9. J Neuroimmunol 102(2):125\u2013130","journal-title":"J Neuroimmunol"},{"key":"9692_CR135","doi-asserted-by":"publisher","first-page":"179","DOI":"10.2174\/157015908785777210","volume":"6","author":"S Stamatovic","year":"2008","unstructured":"Stamatovic S, Keep R, Andjelkovic A (2008) Brain endothelial cell-cell junctions: how to \u2018open\u2019 the blood brain barrier. Curr Neuropharmacol 6:179\u2013192","journal-title":"Curr Neuropharmacol"},{"issue":"5","key":"9692_CR136","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/ijc.20048","volume":"109","author":"S Steiniger","year":"2004","unstructured":"Steiniger S, Kreuter J, Khalansky A, Skidan I, Bobruskin A, Smirnova Z, Severin S, Uhl R, Kock M, Geirger K, Gelperina S (2004) Chemotherapy of glioblastoma in rats using DOXorubicin-loaded nanoparticles. Int J Cancer 109(5):759\u2013767","journal-title":"Int J Cancer"},{"key":"9692_CR137","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1038\/mt.2010.105","volume":"18","author":"D Sun","year":"2010","unstructured":"Sun D, Zhuang X, Xiang X, Liu Y, Zhang S, Liu C, Barnes S, Grizzle W, Miller D, Zhang H (2010) A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol Ther J Am Soc Gene Ther 18:1606\u20131614","journal-title":"Mol Ther J Am Soc Gene Ther"},{"key":"9692_CR138","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1111\/jsm.12705","volume":"11","author":"M Tar","year":"2014","unstructured":"Tar M, Cabrales P, Navati M, Adler B, Nacharaju P, Friedman AJ, Friedman J, Davies KP (2014) Topically applied NO-releasing nanoparticles can increase Intracorporal pressure and elicit spontaneous erections in a rat model of radical prostatectomy. J Sex Med 11:2903\u20132914","journal-title":"J Sex Med"},{"issue":"3","key":"9692_CR139","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ejpb.2004.09.002","volume":"59","author":"M Teixerira","year":"2005","unstructured":"Teixerira M, Alonso M, Pinto M, Barbosa C (2005) Development and characterization of PLGA nanospheres and nanocapsules containing xanthone and 3-methoxyxanthone. Eur J Pharm Biopharm 59(3):491\u2013500","journal-title":"Eur J Pharm Biopharm"},{"key":"9692_CR140","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.ijpharm.2015.12.004","volume":"497","author":"L Thao","year":"2016","unstructured":"Thao L, Byeon H, Lee C, Lee S, Lee E, Choi H, Park E, Youn Y (2016) Pharmaceutical potential of tacrolimus-loaded albumin nanoparticles having targetability to rheumatoid arthritis tissues. Int J Pharm 497:268\u2013276","journal-title":"Int J Pharm"},{"key":"9692_CR141","unstructured":"Upadhyay R, Upadhyay R (2014) Drug delivery systems, CNS protection, and the blood brain barrier, drug delivery systems, CNS protection, and the blood brain barrier. BioMed Res Int BioMed Res In e869269"},{"issue":"1\u20133","key":"9692_CR142","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0168-3659(01)00486-2","volume":"78","author":"A Vila","year":"2002","unstructured":"Vila A, Sanchez A, Tobio M, Calvo P, Alonso M (2002) Design of Biodegradable particles for protein delivery. J Control Release 78(1\u20133):15\u201324","journal-title":"J Control Release"},{"key":"9692_CR143","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1021\/bc034164r","volume":"15","author":"S Vinogradov","year":"2004","unstructured":"Vinogradov S, Batrakova E, Kabanov A (2004) Nanogels for oligonucleotide delivery to the brain. Bioconjug Chem 15:50\u201360","journal-title":"Bioconjug Chem"},{"key":"9692_CR144","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ijpharm.2007.06.016","volume":"347","author":"T Vyas","year":"2008","unstructured":"Vyas T, Shahiwala A, Amiji M (2008) Improved oral bioavailability and brain transport of saquinavir upon administration in novel nanoemulsion formulations. Int J Pharm 347:93\u2013101","journal-title":"Int J Pharm"},{"issue":"3","key":"9692_CR145","doi-asserted-by":"publisher","first-page":"e32568","DOI":"10.1371\/journal.pone.0032568","volume":"7","author":"S Wagner","year":"2012","unstructured":"Wagner S, Zensi A, Wien S, Tschickardt S, Maier W, Vogel T, Worek F, Pietrzik C, Kreuter J, Von Briesen H (2012) Uptake mechanism of ApoE-modified nanoparticles on brain capillary endothelial cells as a blood-brain barrier model. PLoS One 7(3):e32568","journal-title":"PLoS One"},{"key":"9692_CR146","doi-asserted-by":"publisher","first-page":"4196","DOI":"10.1038\/ncomms5196","volume":"5","author":"S Watkins","year":"2014","unstructured":"Watkins S, Robel S, Kimbrough I, Robert S, Ellis-Davies G, Sontheimer H (2014) Disruption of astrocyte-vascular coupling and the blood-brain barrier by invading glioma cells. Nat Commun 5:4196","journal-title":"Nat Commun"},{"key":"9692_CR147","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jconrel.2011.09.059","volume":"157","author":"N Weber","year":"2012","unstructured":"Weber N, Merkel O, Kissel T, Mu\u00f1oz-Fern\u00e1ndez M (2012) PEGylated poly(ethylene imine) copolymer-delivered siRNA inhibits HIV replication in vitro. J Control Release 157:55\u201363","journal-title":"J Control Release"},{"key":"9692_CR148","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jconrel.2013.02.013","volume":"169","author":"C Wischke","year":"2013","unstructured":"Wischke C, Schneider C, Neffe AT, Lendlein A (2013) Polyalkylcyanoacrylates as in situ formed diffusion barriers in multimaterial drug carriers. J Control Release Off J Control Release Soc 169:321\u2013328","journal-title":"J Control Release Off J Control Release Soc"},{"issue":"2","key":"9692_CR149","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1166\/jns.2009.1003","volume":"1","author":"S Wohlfart","year":"2009","unstructured":"Wohlfart S, Bernreuther C, Khalansky A, Theisen A, Weissenberger J, Gelperina S, Glatzel M, Kreuter J (2009) Increased numbers of injections of DOXorubicin bound to nanoparticles lead to enhanced efficacy against rat glioblastoma 101\/8. J Nanoneurosci 1(2):144\u2013151","journal-title":"J Nanoneurosci"},{"key":"9692_CR150","doi-asserted-by":"crossref","unstructured":"Wohlfart S, Khalansky A, Bernreuther C, Michaelis M, Cinatl J Jr, Glatzel M, Kreuter J (2011a) Treatment of glioblastoma with poly(isohexyl cyanoacrylate) nanoparticles. Int J Pharm 415:244\u2013251","DOI":"10.1016\/j.ijpharm.2011.05.046"},{"issue":"1","key":"9692_CR151","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jconrel.2011.05.010","volume":"154","author":"S Wohlfart","year":"2011","unstructured":"Wohlfart S, Khalansky A, Gelperina S, Begley D, Kreuter J (2011b) Kinetics of transport of DOXorubicin bound to nanoparticles across the blood\u2013brain barrier. J Control Release 154(1):103\u2013107","journal-title":"J Control Release"},{"issue":"5","key":"9692_CR152","doi-asserted-by":"publisher","first-page":"e19121","DOI":"10.1371\/journal.pone.0019121","volume":"6","author":"S Wohlfart","year":"2011","unstructured":"Wohlfart S, Khalansky A, Gelperina S, Maksimenko O, Bernreuther C, Glatzel M, Kreuter J (2011c) Efficient chemotherapy of rat glioblastoma using DOXorubicin-loaded PLGA nanoparticles with different stabilizers. PLoS One 6(5):e19121","journal-title":"PLoS One"},{"issue":"2","key":"9692_CR153","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.jconrel.2011.08.017","volume":"161","author":"S Wohlfart","year":"2012","unstructured":"Wohlfart S, Gelperina S, Kreuter J (2012) Transport of drugs across the blood\u2013brain barrier by nanoparticles. J Control Release 161(2):264\u2013273","journal-title":"J Control Release"},{"key":"9692_CR154","doi-asserted-by":"publisher","first-page":"13542","DOI":"10.1021\/ja304649a","volume":"134","author":"M Yan","year":"2012","unstructured":"Yan M, Liang M, Wen J, Liu Y, Lu Y, Chen I (2012) Single siRNA nanocapsules for enhanced RNAi delivery. J Am Chem Soc 134:13542\u201313545","journal-title":"J Am Chem Soc"},{"key":"9692_CR155","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.neuro.2015.12.008","volume":"52","author":"L Yang","year":"2015","unstructured":"Yang L, Zhou Y, Tian W, Li H, Kang-Chu-Li MX, An G, Wang X, Guo G, Ding G (2015) Electromagnetic pulse activated brain microglia via the p38 MAPK pathway. Neurotoxicology 52:144\u2013149","journal-title":"Neurotoxicology"},{"issue":"Suppl 1","key":"9692_CR156","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/753312758","volume":"10","author":"Y Yi","year":"2004","unstructured":"Yi Y, Lee C, Liu Q, Freedman B, Collman R (2004) Chemokine receptor utilization and macrophage signaling by human immunodeficiency virus type 1 gp120: implications for neuropathogenesis. J Neurovirol 10(Suppl 1):91\u201396","journal-title":"J Neurovirol"},{"issue":"3","key":"9692_CR157","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3109\/1061186X.2012.747529","volume":"21","author":"M Yusuf","year":"2013","unstructured":"Yusuf M, Khan M, Khan R, Ahmed B (2013) Preparation, characterization, in vivo and biochemical evaluation of brain targeted piperine solid lipid nanoparticles in an experimentally induced Alzheimer\u2019s disease model. J Drug Target 21(3):300\u2013311","journal-title":"J Drug Target"},{"issue":"1","key":"9692_CR158","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11904-014-0255-3","volume":"12","author":"Z Zayyad","year":"2015","unstructured":"Zayyad Z, Spudich S (2015) Neuropathogensis of HIV: from initial neuroinvasion to HIV-associated neurocognitive disorder (HAND). Curr HIV\/AIDS Rep 12(1):16\u201324","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"1","key":"9692_CR159","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jconrel.2009.03.002","volume":"137","author":"A Zensi","year":"2009","unstructured":"Zensi A, Begley D, Pontikis C, Legros C, Mihoreanu L, Wagner S, Buchel C, von Briesen H, Kreuter J (2009) Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurons. J Control Release 137(1):78\u201386","journal-title":"J Control Release"},{"issue":"10","key":"9692_CR160","doi-asserted-by":"publisher","first-page":"842","DOI":"10.3109\/1061186X.2010.513712","volume":"18","author":"A Zensi","year":"2010","unstructured":"Zensi A, Begley D, Pontikis C, Legros C, Mihoreanu L, B\u00fcchel C, Kreuter J (2010) Human serum albumin nanoparticles modified with apolipoprotein A-I cross the blood-brain barrier and enter the rodent brain. J Drug Target 18(10):842\u2013848","journal-title":"J Drug Target"},{"key":"9692_CR161","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1038\/mt.2011.164","volume":"19","author":"X Zhuang","year":"2011","unstructured":"Zhuang X, Xiang X, Grizzle W, Sun D, Zhang S, Axtell R, Ju S, Mu J, Zhang L, Steinman L, Miller D, Zhang H (2011) Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol Ther J Am Soc Gene Ther 19:1769\u20131779","journal-title":"Mol Ther J Am Soc Gene Ther"}],"container-title":["Journal of Neuroimmune Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-016-9692-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11481-016-9692-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-016-9692-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-016-9692-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T03:12:12Z","timestamp":1692414732000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11481-016-9692-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,2]]},"references-count":161,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["9692"],"URL":"https:\/\/doi.org\/10.1007\/s11481-016-9692-7","relation":{},"ISSN":["1557-1890","1557-1904"],"issn-type":[{"value":"1557-1890","type":"print"},{"value":"1557-1904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,2]]},"assertion":[{"value":"3 May 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}